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Abstract
BACKGROUND: Modern diagnostic strategy in coronary artery 
disease (CAD) makes it necessary not only to establish a dia­
gnosis but also to assess the cardiovascular risk. It is not clear 
which strategy should be followed in the case of women with 
positive ECG stress test results to assess prognosis and start 
appropriate diagnostics and treatment. 
The aim of the study was to assess the prognostic value of 
myocardial perfusion scintigraphy in comparison with coronary 
angiography in women suspected of CAD and with positive ECG 
stress test results.
MATERIAL AND METHODS: The study population comprised 
115 women (mean age 58.08 ± 8.8 years) suspected of CAD, with 
a history of chest pain and positive stress test results, who under­
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went myocardial perfusion scintigraphy. In 58 women coronary 
angiography was performed as the next step of the diagnostic 
procedure. All the patients were interviewed and had a physical 
examination, including the assessment of the cardiovascular 
risk in accordance with the SCORE (Systematic Coronary Risk 
Evaluation) scale and the probability of CAD (POST­TEST) in 
accordance with the ESC guidelines. The gated single photon 
emission computed tomography (GSPECT) with Tc­99m­MIBI 
was considered positive if moderate perfusion changes were 
observed in at least two segments or severe reversible perfusion 
disorders were found, regardless of the number of involved seg­
ments. The degree of coronary stenosis was assessed visually 
and changes greater than 50% stenosis of the luminal diameter 
were considered haemodynamically significant. 
RESULTS: The evaluation period covered 43.2 ± 30.8 months 
on average. The sensitivity of myocardial perfusion scintigraphy 
against cardiovascular events was 100% and the sensitivity of 
coronary angiography was 92.3%. The specificity was 93.1% 
and 88.9% respectively.
The PPV of scintigraphy for cardiovascular events was 65% and of 
coronary angiography was 70.6%. The NPV was 100% and 97.6% 
respectively. The accuracy of myocardial perfusion scintigraphy for 
cardiovascular events was 93.9% and the accuracy of coronary 
angiography for cardiovascular events was 89.7%. The survival 
analysis confirmed the high prognostic value of SPECT and coro­
nary angiography. However, if compared, myocardial perfusion 
scintigraphy was a better predictor of survival without cardiovas­
cular events than coronary angiography was (c2 = 9.39, p < 0.01).
The most important factors in assessing the cardiovascular risk 
in the study population included: positive result of myocardial 
perfusion scintigraphy, positive result of coronary angiography, 
and high SCORE and high POST­TEST values. 
CONCLUSIONS: Myocardial perfusion scintigraphy is superior 
to coronary angiography in the prediction of necessary revas­
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cularisation procedures in women suspected of coronary artery 
disease and with positive stress test results. 
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Background
Coronary artery disease (CAD) is the main cause of death in 
the female population [1], and women diagnosed with CAD have 
worse prognosis compared to men [2]. There is a range of distinct 
differences related to the CAD in women in terms of the clinical 
picture, risk factors and value of diagnostic methods [3–6]. 
According to contemporary standards [7, 8] it is recommended 
to begin the diagnosis of the coronary artery disease with an ECG 
stress test, notwithstanding the sex-related differences in the diag-
nostic value of this procedure. A negative result of the stress test 
is of major importance in excluding the disease, especially in the 
case of women with low risk of coronary artery disease prior to 
the test. On the other hand there is no definite procedure to be 
followed in the case of women with positive stress test results. 
Based on the guidelines for the general population, an invasive 
procedure can be performed in this group. However, it is known 
that about half of women qualified in the Women’s Ischemia Syn-
drome Evaluation study (WISE) for coronary angiography based on 
the previous recommendations were found to have no significant 
changes in the coronary arteries, and negative results of coronary 
angiography were not related to the expected good prognosis [6]. 
It is not clear what tests should be carried out in the case of 
women with positive ECG stress test results so as to ensure that 
the patient benefits as much as possible from the diagnostic 
process in terms of disease diagnosis as well as evaluation of 
the cardiovascular risk. 
As a result it was decided to evaluate the diagnostic and prog-
nostic value of myocardial perfusion scintigraphy and coronary 
angiography in a group of women with positive ECG stress test 
results. 
Material and methods
The study group for the evaluation of the prognostic value 
of myocardial perfusion scintigraphy and coronary angiography 
comprised 115 female patients with chest pain and positive ECG 
stress test results who had been referred for primary CAD diag-
nostics from across Poland. All the patients gave their consent 
to undergo the procedures and to provide clinical data for the 
purpose of long-term evaluation. Also the study was approved by 
the Bioethics Commission of the Military Physician Association.
The average age of the patients was 58.08 ± 8.8 and 26.1% of 
the patients were older than 65 years of age. All the patients under-
went myocardial perfusion scintigraphy, and 58 of them also coro-
nary angiography as the next stage of the CAD diagnosis process. 
Exclusion criteria included: positive history of myocar-
dial infarction or coronary artery revascularisation, presence of 
pathological Q wave or left bundle branch block in resting ECG, 
pregnancy, concomitant diseases preventing from performing 
diagnostic examinations and completion of the evaluation, age 
below 18 years, conditions limiting the ability of understanding the 
nature of the procedures or making an informed decision, lack of 
patient’s consent to participate in the study. 
Clinical evaluation
Prior to the imaging examination, all the patients were in-
terviewed to evaluate the risk of atherosclerosis, pain level and 
received medication. The clinical classification of chest pain 
was performed as recommended by the European Society of 
Cardiology (ESC) [7]. 
Typical chest pain was evaluated according to the classification 
criteria of the Canadian Cardiovascular Society (CCS) [9]. All the 
patients were evaluated for the risk of cardiovascular events in ac-
cordance with the Systematic Coronary Risk Evaluation (SCORE) 
scale of the European Society of Cardiology [10]. Physical exami-
nation included full assessment of heart rate, arterial pressure, 
body height, body weight and waist circumference. 
ECG stress test
All the patients underwent ECG stress test. The test 
was performed on a treadmill according to the Bruce protocol. 
The patients received no beta-adrenolytics for 48 hours prior to 
the test. During the test their clinical condition, ECG and arterial 
pressure were monitored. According to the study assumptions, 
all the patients had positive ECG stress test results. Additio nally, 
the maximum pulse rate, number of the achieved metabolic 
equivalents (MET), stage and reason for termination, if any, were 
analysed. Each patient was evaluated for the post-test probability 
of coronary artery disease (POST-TEST) according to the recom-
mendations of the European Society of Cardiology [7]. Also the 
post-test normalisation of heart rate was assessed based on the 
heart rate recovery (HRR) value calculated as a difference between 
the maximum heart rate and the heart rate after 1 minute.
Myocardial perfusion scintigraphy
Gated myocardial perfusion scintigraphy was carried out for all 
the patients with Tc-99m-MIBI single photon emission computed 
tomography (SPECT). The examination based on a 2-day protocol 
was performed following intravenous administration of 740 MBq 
Tc-99m-MIBI at the end of the stress test and after 2 days in resting 
condition. The isotope was injected one minute prior to the com-
pletion of the treadmill stress test. Gated single photon emission 
computed tomography (GSPECT - Gated SPECT) was performed 
to enable evaluating both perfusion and left ventricular function. 
No adjustments for absorption were included. The analysis of left 
ventricular perfusion disorders was carried out using the XpertPro 
system with the Cedars Emory Quantitative Analysis (CEQUAL) 
software. A 16-segment model of the left ventricular muscle 
was applied [11]. The results of perfusion examination in specific 
segments of the left ventricle - magnitude and intensity of perfu-
sion disorders — were evaluated on a semi-quantitative basis: 
1 — insignificant, 2 — moderate, 3 — significant [11]. Moderate 
reversible perfusion disorders involving at least 10% of the left 
ventricular muscle or significant reversible perfusion disorders, 
regardless of the number of involved segments, were considered 
a positive result of the examination. Additionally, a Hermes Nuclear 
Diagnostics station with Quantitative Gated SPECT (QGS) software 
was used for the assessment of GSPECT results. The software 
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made it possible to calculate post-test and resting parameters of 
left ventricular function, such as: left ventricular ejection fraction, 
end-diastolic volume and end-systolic volume.
Coronary angiography
A typical coronary angiography procedure was performed in 58 
women using Philips Integris 2000 with standard projections du-
ring the test [12]. The degree of stenosis was assessed visually 
on a semi-quantitative basis: 0 — no stenosis, 1 — up to 50% 
stenosis, 2 — 50–70% stenosis, 3 — greater than 70% stenosis of 
the coronary artery luminal diameter. Stenosis greater than 50% of 
the luminal diameter was considered haemodynamically significant 
in coronary angiography. Also the number of coronary vessels with 
significant stenosis was analysed.
Analysis of clinical data for long-term evaluation
The patients were evaluated at the beginning and at the 
end of the evaluation period. The average evaluation period 
covered 43.2 ± 30.8 months. The occurrence of cardiovascular 
events was analysed, and a cardiovascular event was defined as: 
percutaneous coronary angioplasty or coronary artery bypass graft 
surgery, myocardial infarction, cardiac arrest, death, cerebral 
stroke, transient cerebral ischemic episode, percutaneous vascu-
lar procedures and vascular surgeries on non-coronary arteries, 
implantation of cardiac stimulation systems. 
Statistical analysis
Individual numerical values were presented as an aver-
age ± standard deviation. The classic t-Student for independent 
sample tests was used to determine the significance of diffe-
rences between average values. Two groups of data, collected 
according to the unrelated data model, were compared on an or-
dinal scale using the Mann-Whitney test described by Santner and 
Duffy. The survival assessment was based on the Kaplan-Meier 
estimator and the log-rank test was used to compare the data. 
Each clinical factor was evaluated in terms of prognostic value 
based on the Cox regression model. To evaluate the independ-
ent prognostic value of the analysed parameters a multiple factor 
analysis was performed together with a discriminant analysis which 
belongs to multidimensional scaling methods. The value p < 0.05 
was assumed as statistically significant [13].
Results
The clinical profile of the study population is shown in Table 1. 
Myocardial perfusion scintigraphy was performed for all the 
patients, but in the case of 49 patients it was carried out both 
stress test and in resting condition, and in the case of 66 pa-
tients the examination in resting condition was not carried out at 
all on account of normal perfusion results in the ECG stress test. 
Perfusion disorders were determined for 26 patients: in 6 pa-
tients the changes were observed in 1 segment, in 13 — 2 seg-
ments, in 5 — 3 segments and in 2 patients — 4 segments. In 14 
patients perfusion disorders showed moderate reversibility and in 
12 patients significant reversibility. Positive perfusion scintigraphy 
results were obtained for 20 patients (17.4%). All the patients had 
normal rate of ejection fraction as well as end-systolic and 
end-diastolic volumes.
58 women underwent both myocardial perfusion scintigraphy 
and coronary angiography. The decision regarding coronary 
angiography was based mainly on the clinical picture, taking 
into particular consideration persistent chest pain in the case of 
patients with positive results of myocardial perfusion scintigra-
phy. Positive coronary angiography results were obtained for 17 
patients (29.3%). The average stenosis of the luminal diameter 
was 0.91 ± 1.23 and the average number of involved coronary 
vessels 0.62 ± 0.89. 
Analysis by cardiovascular events 
The average evaluation period covered 43.2 ± 30.8 months. 
During the evaluation period 13 cardiovascular events (11.3% of 
the population) occurred, including: 8 percutaneous coronary 
angioplasty procedures, 4 coronary artery bypass graft surgeries, 
1 cerebral stroke.
The patients were qualified for revascularisation proce-
dures based on their clinical picture (chest pain) and results of 
additional tests (positive result of coronary angiography indicative 
of significant stenosis of coronary arteries and significant rever-
sible perfusion disorders in the regions supplied with blood via the 
stenosed coronary arteries as observed in myocardial perfusion 
scintigraphy). 
The groups of patients with a positive history of cardiovascular 
events and those with a negative history of such events were com-
Table 1. Clinical profile of the study population 
n = 115
Age (years) 58.08 ± 8.8
Arterial hypertension 76 (66.1%)
Type 2 diabetes 6 (5.2%)
Hyperlipidaemia 74 (64.3%)
BMI 26.95 ± 3.67
Metabolic syndrome 44 (38.3%)
Smoking 51 (44.3%)
Physical activity
Low 32 (27.8%)
Moderate 72 (62.6%)
High 11 (9.6%)
Positive family history 40 (34.8%)
Chest pain
Non-coronary 48 (41.7%)
Atypical 41 (35.7%)
Typical 26 (22.6%)
CCS:
I 2 (1.7%)
II 23 (20%)
III 1 (0.9%)
Other problems 28 (24.3%)
Score risk ≥ 5%/10 years 5.11 ± 4.86
45 (39.1%)
Pre-test (%)* 36.77 ± 29.8
*Pre-test probability of coronary artery disease
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Table 2. Comparison of the clinical data for patients with a negative history of cardiovascular events and those with a positive history of 
cardiovascular events
Group I Patients with a negative history  
of cardiovascular events 
N = 102
Patients with a positive history  
of cardiovascular events 
N = 13
P
Age (years) 57.39 ± 8.86 63.46 ± 6.63 <0.02
Arterial hypertension 65 (63.7%) 11 (84.62%) Not significant
Type 2 diabetes 3 (2.9%) 3 (23.1%) < 0.0001
Hyperlipidaemia 69 (67.6%) 5 (38.5%) Not significant
BMI 26.97 ± 3.68 26.77 ± 3.70 Not significant
Metabolic syndrome 40 (39.2%) 4 (30.8%) Not significant
Smoking 43 (42.2%) 8 (61.54%) Not significant
Physical activity Not significant
Low 29 (28.4%) 3 (23.1%)
Moderate 63 (61.8%) 9 (69.2%)
High 10 (9.8%) 1 (7.7%)
Positive family history 33 (32.4%) 7 (53.8%) Not significant
Chest pain < 0.001
Non-coronary 47 (46.1%) 1 (7.7%)
Atypical 37 (36.3%) 4 (30.8%)
Typical 18 (17.6%) 8 (61.5%)
CCS: < 0.001
I 2 (2.0%) 0 (0.0%)
II 16 (15.6%) 7 (53.8%)
III 0 (0.0%) 1 (7.7%)
Other problems 27 (26.5%) 1 (7.79%) Not significant
Score risk ≥ 5%/10 years 4.62 ± 4.62
35 (34.3%)
9.0 ± 5.13
10 (76.9%)
< 0.001
< 0.01
Pre-test (%)* 32.62 ± 28.08 69.28 ± 22.41 < 0.0001
*Pre-test probability of coronary artery disease 
Table 3. Comparison of stress test results for patients with a negative history of cardiovascular events and those with a positive history of 
cardiovascular events
ECG stress test Patients with a negative history  
of cardiovascular events 
N = 102
Patients with a positive history  
of cardiovascular events 
N = 13
P
Duration of stress test (min) 5.73 ± 2.52 4.52 ± 1.94 Not significant
Number of achieved mets 7.87 ± 2.95 4.45 ± 1.36 < 0.001
Number of stress test stages 2.31 ± 0.88 1.83 ± 0.41 Not significant
Maximum heart rate during stress test (min) 153.85 ± 22.78 132.4 ± 9.71 < 0.01
% of the predicted maximum heart rate 95.49 ± 13.53 87.4 ± 6.96 Not significant
HRR* 38.23 ± 23.91 25.0 ± 3.0 < 0.01
Post-test (%)** 44.06 ± 29.53 80.46 ± 17.83 < 0.0001
*Heart rate recovery; **post-test probability of coronary artery disease
pared in terms of their clinical data and the results of the stress test, 
myocardial perfusion scintigraphy and coronary angiography. The 
results of the analysis are shown in Tables 2–4. 
Table 2. The patients with a positive history of cardiovascular 
events were older to a statistically significant extent and consi-
derably more often diagnosed with Type 2 diabetes. Typical chest 
pain was observed more frequently to a statistically significant 
degree in the patients s/p cardiovascular events compared 
to those with a negative history of such events. The CCS level 
was also significantly higher in the group s/p cardiovascular events. 
Non-coronary problems were observed more frequently in the 
group with a negative history of cardiovascular events. Both the 
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risk of cardiovascular events evaluated according to the SCORE 
scale and the pre-test probability of coronary artery disease were 
to a statistically significant degree higher in the group with a posi-
tive history of cardiovascular events compared to the group with 
a negative history of such events.
Table 3. The number of the achieved metabolic equiva-
lents and the maximum heart rate were significantly lower in the 
group with a positive history of cardiovascular events compared 
to the group with a negative history of such events. The HRR 
value was significantly lower in the group with a positive history of 
cardiovascular events. The post-test probability of coronary artery 
disease was to a statistically significant extent higher in the group 
with a positive history of cardiovascular events compared to the 
group with a negative history of such events. 
Table 4. Positive results of myocardial perfusion scintigraphy 
and coronary angiography were observed more frequently in the 
group with a positive history of cardiovascular events. 
Based on the conducted analyses the prognostic value of 
myocardial perfusion scintigraphy and coronary angiography in 
predicting cardiovascular events was calculated. The results are 
shown in Table 5.
Table 5. The analysis of survival without cardiovascular 
events depending on the results of myocardial perfusion scinti-
graphy and coronary angiography was carried out. The results of 
the survival analysis are shown in Figures 1 and 2. 
Figure 1. Negative results of myocardial perfusion scintigraphy 
were obtained for 95 patients (82.6%) and positive results for 20 
patients (17.4%). In the group with negative results of myocardial 
perfusion scintigraphy no cardiovascular events were observed. 
In the group with positive scintigraphy results only 35% suffered 
no cardiovascular events. The average survival period without 
cardiovascular events in the group with positive scintigraphy 
results was 20.55±32.07 months. 
Figure 2. Negative results of coronary angiography were 
obtained for 41 patients (70.7%) and positive results for 17 
patients (29.3%). In the group with negative results of coronary 
angiography no cardiovascular events were observed in 97.6% 
of the patients and in the group with positive results of coronary 
angiography 29.4% of the patients suffered no cardiovascular 
events. Positive results of coronary angiography were correlated 
with shorter time — to a statistically significant degree — to the 
occurrence of a cardiovascular event (p < 0.0001). The average 
Table 4. Comparison of myocardial perfusion scintigraphy and coronary angiography results for patients with a negative history of 
cardiovascular events and those with a positive history of cardiovascular events
Patients with a negative history  
of cardiovascular events 
N = 102
Patients with a positive history  
of cardiovascular events 
N = 13
P
Positive scintigraphy results 7 (6.9%) 13 (100%) < 0.0001
Magnitude 0.2 ± 0.55 2.0 ± 0.0 < 0.0001
Intensity 0.15 ± 0.41 1.77 ± 0.44 < 0.0001
Positive coronary angiography results 5 (11.1%)† 12 (92.3%) < 0.0001
Degree of luminal diameter stenosis 0.4 ± 0.75 2.69 ± 0.85 < 0.0001
Number of involved vessels 0.29 ± 0.5 1.77 ± 1.01 < 0.0001
†n = 45
Table 5. Comparison of the prognostic value of myocardial perfusion scintigraphy and coronary angiography
Myocardial perfusion scintigraphy Coronary angiography 
Prognostic value of results in predicting cardiovascular events
Sensitivity 
Specificity
100%
93.1%
92.3%
88.9%
Predictive value of positive results
Predictive value of negative results
Accuracy of results in predicting cardiovascular events
65%
100%
93.9%
70.6%
97.6%
89.7% 
Figure 1. Survival curves without cardiovascular events for patients 
with negative and positive results of myocardial perfusion scintigraphy
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time to the occurrence of an event in the group with negative 
results was 54.98 ± 33.35 and in the group with positive re-
sults 15.76 ± 30.2 months. Both in the case of scintigraphy and 
coronary angiography survival curves without cardiovascular 
events become separated at an early stage and enable good 
differentiation of the population in terms of the higher risk of car-
diovascular events. It is noticeable that in the group with negative 
results of myocardial perfusion scintigraphy no patients were 
observed to have cardiovascular events. The comparative 
analysis demonstrated that myocardial perfusion scintigraphy had 
a higher value compared to coronary angiography for the evalua-
tion of survival without cardiovascular events (c2 = 9.39; p < 0.01). 
The statistical power of each component of the patients’ 
evaluation was compared with the suspicion of coronary artery 
disease in terms of the best prognosis of cardiovascular events. 
The results of the analysis are shown in Figure 3. 
Figure 3. Based on the analysis it was demonstrated that 
the major factors contributing to the higher probability of cardio-
vascular events included diagnosed Type 2 diabetes (c2 = 9.45; 
p < 0.05) and also the determined high risk of cardiovascular 
events evaluated according to the SCORE scale (c2 = 8.79; 
p < 0.05 for SCORE ≥ 5%) as well as high post-test probability 
of coronary artery disease calculated according to the recom-
mendations of the European Society of Cardiology (c2 = 11.42; 
p < 0.05 for POST-TEST ≥ 80%). The determination of typical 
chest pain appeared to be of substantial importance (c2 = 12.69; 
p < 0.001). However, the highest statistical power was deter-
mined for a positive result of myocardial perfusion scintigraphy 
(c2 = 69.92; p < 0.0001) and a positive result of coronary angio-
graphy (c2 = 32.09; p < 0.0001).
The multiple factor analysis showed that the presence of Type 
2 diabetes (tolerance 0.77) and SCORE value (tolerance 0.39) 
have an independent prognostic value in predicting cardiovascular 
events in the study population, and also the CCS class (tolerance 
0.04) and the presence of typical angina pectoris (tolerance 0.03) 
contribute to a small, although significant extent to the discrimina-
tion process. 
Discussion
The study showed that myocardial perfusion scintigraphy 
is highly sensitive (100%) and specific (93.1%) in predicting car-
diovascular events which included mostly revascularisation proce-
dures in the study population. The analysis of survival showed that 
a negative scintigraphy result guarantees very good prognosis in 
the case of the patients suspected of CAD as no patients with 
negative scintigraphy results were observed to have cardiovascular 
events, including any necessary revascularisation procedures, 
which contributes to a 100% predictive value of negative scinti-
graphy results. Metz et al. [14], in a meta-analysis aimed at sum-
marising the prognostic value of myocardial perfusion scintigraphy 
for patients suspected of CAD, demonstrated that the predictive 
value of negative results of this examination was extremely high, 
regardless of patient’s sex and received medication, and equal 
to 98.8%. Thus, results obtained in this study are consistent with 
the calculations carried out in the meta-analysis referred to above.
Performance of coronary angiography in the case of pa-
tients diagnosed with coronary artery disease makes it possible 
Figure 2. Survival curves without cardiovascular events for patients 
with negative and positive results of coronary angiography
Figure 3. Statistical power (c2) for the components of evaluation of the patients suspected of CAD in predicting cardiovascular events. Statistically 
significant parameters are shown in red
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to enhance the risk stratification with an additional prognostic 
value attributable to the intensity and magnitude of atheroscle-
rotic changes in coronary arteries. Since the publication of the 
Coronary Artery Surgery Study (CASS) results [15], coronary 
angiography has continued to be the gold standard in the evalu-
ation of patients suspected of CAD, however more and more 
often its prognostic value is considered disputable, especially 
in the context of CAD in the female population. In the WISE 
study [7] it was demonstrated that a non-pathological result of 
coronary angiography is not correlated with good prognosis in 
the female population. In the study conducted by Sharaf et al. 
[6] 9.4% of women without significant changes in coronary ar-
teries confirmed during angiography died or suffered non-fatal 
myocardial infarction over the following 4 years. However, in 
this study, contrary to the WISE study, it was shown that coronary 
angiography has a high prognostic value in predicting cardiovas-
cular events which can be explained by the fact that the women 
included in the WISE study belonged to American population 
which according to epidemiological surveys is subject to greater 
exposure due to cardiovascular diseases [16]. A more probable 
reason for the higher prognostic value of coronary angiography 
can be the fact that the end points of the evaluation period in 
this study were mostly revascularisation procedures. It seems that 
the evaluation period in this study was too short for a full assess-
ment of long-term prognosis in the case of patients with signifi-
cant changes in coronary arteries and for definite confirmation 
of the predictive value of both positive and negative results of 
coronary angiography for such hard end points as myocardial 
infarction and cardiovascular death. 
The assessment of survival without cardiovascular events in the 
study population with positive ECG stress test results was indica-
tive of high prognostic value of negative results of both myocardial 
perfusion scintigraphy and coronary angiography. However, the 
comparative analysis would suggest that myocardial perfusion 
scintigraphy, and in particular a negative result thereof, has a higher 
prognostic value in predicting cardiovascular events than coro-
nary angiography. This fact is especially significant in the case 
of patients suspected of coronary artery disease for whom the 
observed end points were mostly revascularisation procedures. 
In the material in this study it was shown that if no stress-induced 
myocardial ischemia was observed in the functional examination, 
e.g. perfusion imaging, then despite the determined significant 
coronary stenosis no revascularisation was performed and more 
importantly, no cardiovascular events were reported in the case 
of these patients. Similar results were obtained in the study of 
Nalla mothu et al. [17] in which 2700 patients suspected of CAD un-
derwent myocardial perfusion scintigraphy and it was determined 
that the lack of perfusion disorders was correlated to a statistically 
significant extent with lower percentage of both serious cardiovas-
cular complications and necessary revascularisation procedures. 
In the Polish study [11] it was also demonstrated based on a group 
of 174 patients suspected of CAD that scintigraphy is more useful 
compared to coronary angiography in evaluating the risk of future 
cardiovascular events, however no analysis of sex-related diffe-
rences in the prognostic value of isotopic examination was per-
formed for the study population.
In the Economics of Myocardial Perfusion Imaging in Europe 
(EMPIRE) study [18] the authors showed that myocardial perfusion 
scintigraphy in the case of patients suspected of CAD enables not 
only accurate determination of diagnosis and prognosis, but also 
contributes to reducing costs as a result of the elimination of an un-
necessary invasive procedure. However, in the Polish population 
coronary angiography is used for diagnosing CAD in 22.5% of 
women suspected thereof, while myocardial perfusion scintigraphy 
in only 0.8% [19]. This fact can be attributable to relatively high 
accessibility of invasive procedures, but also to the widely ac-
cepted — since the publication of the CASS results [15] — belief 
that the primary purpose of the evaluation of patients suspected of 
coronary artery disease is to visualise any coronary artery stenoses. 
On the other hand the WISE study results [20] indicate that such 
methodology is unsuccessful when diagnosing coronary artery 
disease in the female population. Due to the differences in the 
clinical picture and in the primary diagnostics in this population, for 
a significant percentage of cases it is difficult to determine correct 
diagnosis, and thus, to evaluate the risk of cardiovascular compli-
cations on an individual basis for each patient. The results obtained 
in this study confirm the existing diagnostic problems. It would 
seem plausible that it is necessary to take into consideration 
all the clinical data to select such a group of female patients for 
whom, on account of the intensity of symptoms, risk factors and 
stress test results, performance of coronary angiography would 
be most beneficial as a result of qualification for possible revascu-
larisation or intensified prevention of future adverse cardiovascular 
events. It was shown in this study that the following factors are of 
fundamental importance in the evaluation of patients suspected of 
coronary artery disease: diagnosed Type 2 diabetes, presence of 
typical chest pain, evaluation of the cardiovascular risk according 
to the SCORE scale and the post-test probability of coronary artery 
disease according to the POST-TEST scale.
Conclusions
The results obtained in this study are indicative of high pro-
gnostic value of myocardial perfusion scintigraphy in the case of 
women with positive ECG stress test results. It was determined 
that the lack of reversible perfusion disorders implies very good 
prognosis. 
In the population of women suspected of coronary artery di-
sease and with positive ECG stress test result myocardial perfusion 
scintigraphy is a better predictor of necessary revascularisation 
compared to coronary angiography.
It was shown in this study that the evaluation of the cardio-
vascular risk according to the SCORE scale and of the post-test 
probability of coronary artery disease according to the recom-
mendations of the European Society of Cardiology are of critical 
importance in the diagnostics and assessment of prognosis in the 
case of women suspected of coronary artery disease.
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